About Us
Pharmaceuticals for a Changing World
Martin Dow is the bench mark for excellence in pharmaceutical industry, expanding with more than 1000 employees countrywide. Martin Dow has excelled in world class branded generics for half a decade and now growing in emerging markets. We market world-class branded generics which are developed, formulated and manufactured at our cGMP compliant manufacturing facility.
Martin Dow has recently acquired Roche manufacturing facility in Pakistan. This exchange of strategic ideas, modules and technology has established a globally certified infrastructure keeping the legacy of Roche alive. This collaboration has also resulted in the licensing of Roche's leading brands which are now manufactured and marketed under Martin Dow's tag. We have acolyte Roche's true fingerprints hence achieving the status of brilliance in a very short span of time. Martin Dow not only took over the manufacturing facility but also captured the legacy of operational excellence and maintaining high quality standards.
Our Mission
At Martin Dow, our highest proof of virtue is that we possess boundless power of excellence directed towards serving humanity. Our corporate values are at par with international standards, covering all socio-ethical, legal and environmental boundaries. We believe in treating every employee with dignity & respect and in creating a culture of continuous learning & development. We firmly believe in establishing a long term & transparent relationship with our business associates by entering into value added ventures which are mutually beneficial. And, we never forget to share the benefits of our success with the communities and be socially responsible.
Our Vision
At Martin Dow, the true worth of our business is measured by the objectives we want to pursue. Henceforth, our Vision is:
- To be amongst top-5 pharmaceutical companies in Pakistan by the year 2015
- To have a strong presence into Emerging Pharmaceutical Markets of the World
- To acquire advanced technologies thereby ensuring our presence in highly specialized segments
